Verastem, Inc. (NASDAQ:VSTM) Q4 2025 Earnings Call Transcript March 4, 2026 Verastem, Inc. misses on earnings expectations.

A staggering 94% of Americans use caffeine, 64% of whom do so on a daily basis. It’s the energy enhancer people start their ...

Thank you, Julissa. 2025 was a truly transformative year for Verastem as we transition to a commercial stage company ...

We look forward to sharing additional Phase 1/2 data next week at the Muscular Dystrophy Association's annual meeting and ...

A conserved glucagon signaling pathway links high-fat diet-induced metabolic imbalance to cardiac arrhythmia through hormone-producing cells and heart-innervating neurons that regulate rhythmicity.

A major problem in the treatment of addiction is relapse, which is often caused by the powerful and long-lasting memories of the drug experience. Drugs of abuse can hijack or impair specific synaptic ...